Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
47.01 USD | +1.84% | +9.84% | +16.80% |
05-13 | Oppenheimer Adjusts Price Target on Soleno Therapeutics to $59 From $65, Maintains Outperform Rating | MT |
05-10 | Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target | MT |
- Stock Market
- Equities
- SLNO Stock
- News Soleno Therapeutics, Inc.